ctDNA sequencing efficiently detects KIT/PDGFRA mutations and prognosticates outcomes in patients with TKI‐resistant gastrointestinal stromal tumor (GIST) treated with avapritinib. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.